John P. Gandolfo
Independent DirectorMr. John P. Gandolfo, CPA, serves as Independent Director at Oragenics, Inc. since October 04, 2023. He had been Chief Financial Officer of Eyenovia, Inc. since December 18, 2017 until September 2024 and served as its Secretary since December 18, 2017 until November 2024. Mr. Gandolfo had been Independent Director at Odyssey Health, Inc. (formerly known as Odyssey Group International, Inc.) since October 23, 2019 until October 5, 2023 and serves as Independent Director at electroCore, Inc. since April 2, 2020. Mr. Gandolfo served as Consultant of Xtant Medical Holdings, Inc. since September 1, 2017 until November 30, 2017. Mr. Gandolfo served as the Chief Financial Officer of Xtant Medical Holdings, Inc. (also known as Bacterin International, Inc) from July 6, 2010 to September 2017 and served as its Treasurer and Secretary until September 1, 2017. Mr. Gandolfo served as Interim Co-Chief Executive Officer of Bacterin International Holdings from April 5, 2013 to August 14, 2013. He served as the Chief Financial Officer of Amorcyte, LLC (formerly, Amorcyte Inc.). He served as Interim Chief Financial Officer at Bacterin International Holdings, Inc. since June 30, 2010 and K-Kitz, Inc. until June 30, 2010. Prior to joining Bacterin, Mr. Gandolfo served as the Chief Financial Officer of Progenitor Cell Therapy, LLC from January 2009 to June 2010. He began his professional career at Price Waterhouse. Mr. Gandolfo has experience as a Chief Financial Officer of multiple rapidly growing private and publicly held companies with a primary focus in the life sciences, healthcare and medical device areas. He had direct responsibility over private and public capital raising, financial management, mergers and acquisition transactions and SEC reporting throughout his professional career. Mr. Gandolfo served as Chief Financial Officer of Power Medical Interventions, Inc. from January 2007 to January 2009 and also served as its Principal Accounting Officer. Prior to joining Power Medical Interventions, he served as the Chief Financial Officer, Principal Accounting Officer and Vice President of Finance at Bioject Medical Technologies Inc., from September 2001 to May 2006 and was responsible for the successful licensing of its technology to various pharmaceutical companies. Prior to joining Bioject, he served as the Chief Financial Officer of Capital Access Network, Inc., from 2000 to September 2001. Mr. Gandolfo served as Senior Vice President and Chief Financial Officer of Worldwide Xceed Group, Inc. from November 12, 1999 to September 2000. He served as the Chief Financial Officer and Chief Operating Officer of Impath Inc. from 1994 to 1999. Prior to joining Impath, Mr. Gandolfo served as the Chief Financial Officer of Medical Resources Inc. from 1987 to 1994. He served as a Director of Bacterin International Holdings, Inc. from July 9, 2013 to August 14, 2013. He served as a Director of Bioject Medical Technologies Inc. from September 2006 to May 2007. He is a Certified Public Accountant. Mr. Gandolfo holds a Bachelor of Arts degree in Business Administration from Rutgers University.
Positions
- Company NameelectroCore, Inc.Stock CodeECORPositionIndependent DirectorColleagues
- TJThomas J. ErricoFounder & Independent Chairman
- JSJoshua S. LevCFO, Interim CEO, President & Director
- MFMichael FoxCOO, Interim CEO, Interim President & Director
- JAJennifer A. HayesVice President of HR & Employee Success
- PSPeter S. StaatsChief Medical Officer
- JPJohn P. GandolfoIndependent Director
- PDPatricia Derrico WilberIndependent Director
- Company NameOragenics, Inc.Stock CodeOGENPositionIndependent DirectorColleagues
- JHJanet HuffmanCEO, President, Secretary & Treasurer
- CLCharles L. PopeIndependent Chairman of the Board
- JSJohn SpencerChief Financial Officer
- JPJames P. KellyChief Medical Officer
- WFWilliam Franklin PeacockChief Clinical Officer
- FWFrederick W. TellingIndependent Director
- AWAlan W. DuntonIndependent Director
- RCRobert Clayton KoskiIndependent Director
